GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q3 2024
Top Holdings46 positions
CVS HEALTH CORP | 11.9M | $751.2M | 14.5% | $57.60 | +1.17% | 4 qtrssince 2023-Q4 | Increased 79 |
TENET HEALTHCARE CORP COM NEW | 2.7M | $441.9M | 8.5% | $34.63 | +379.96% | 24 qtrssince 2018-Q4 | Decreased 0 |
GLOBAL PMTS INC | 4.1M | $424.1M | 8.2% | $124.24 | -19.51% | 16 qtrssince 2020-Q4 | Increased 79 |
CIGNA CORP NEW | 1.1M | $364.3M | 7.0% | $230.05 | +44.50% | 24 qtrssince 2018-Q4 | Decreased 0 |
CORTEVA INC | 5.2M | $308.2M | 6.0% | $51.00 | +13.38% | 20 qtrssince 2019-Q4 | Increased 63 |
iShares Trust RUSSELL 2000 ETF | 1.3M | $295.6M | 5.7% | — | — | — | Increased — |
DXC TECHNOLOGY CO | 11.2M | $231.9M | 4.5% | $31.09 | -33.27% | 24 qtrssince 2018-Q4 | Increased 71 |
CLARIVATE PLC | 26.2M | $186.3M | 3.6% | $9.07 | -23.28% | 10 qtrssince 2022-Q2 | Increased 58 |
UNIVERSAL HLTH SVCS INC | 733,260 | $167.9M | 3.2% | $147.97 | +54.59% | 8 qtrssince 2022-Q4 | Decreased 0 |
Expedia Group Inc | 1.1M | $161.5M | 3.1% | $119.61 | +23.65% | 9 qtrssince 2022-Q3 | Increased 87 |
TEVA PHARMACEUTICAL INDS LTD | 8.5M | $152.4M | 2.9% | $13.85 | +30.07% | 4 qtrssince 2023-Q4 | Decreased 0 |
State Street Spdr S&p 500 Etf Trust TR UNIT | 232,900 | $133.6M | 2.6% | — | — | — | Unchanged — |
MCKESSON CORP | 266,945 | $132M | 2.6% | $146.03 | +232.57% | 24 qtrssince 2018-Q4 | Increased 53 |
ALIGHT INC | 17.7M | $131.1M | 2.5% | $8.42 | -17.66% | 9 qtrssince 2022-Q3 | Decreased 0 |
ELEMENT SOLUTIONS INC COM | 4.5M | $122.4M | 2.4% | $20.99 | +26.53% | 23 qtrssince 2019-Q1 | Decreased 0 |
US Foods Holding Corp | 1.8M | $111.5M | 2.2% | $41.72 | +47.40% | 12 qtrssince 2021-Q4 | Decreased 0 |
DUN & BRADSTREET HLDGS INC | 9.6M | $110M | 2.1% | — | — | 9 qtrssince 2022-Q3 | Increased 84 |
Amazon.com, Inc. | 475,429 | $88.6M | 1.7% | $140.85 | +32.29% | 7 qtrssince 2023-Q1 | Increased 62 |
VIATRIS INC COM | 7.6M | $87.9M | 1.7% | $9.82 | +8.91% | 4 qtrssince 2023-Q4 | Increased 55 |
Marvell Technology Inc | 1.2M | $84M | 1.6% | $69.46 | +1.72% | 4 qtrssince 2023-Q4 | Increased 62 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $5.2B across 46 positions as of Q3 2024. Top holdings: CVS (14.5%), THC (8.5%), GPN (8.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 7 new positions, 10 exits, 17 increased. Top move: EXPE (INCREASED, conviction 87). Portfolio: $5.2B across 46 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR